Start Time Optimization of Biologics in Polyarticular JIA
Status: | Active, not recruiting |
---|---|
Conditions: | Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 2 - 18 |
Updated: | 9/7/2018 |
Start Date: | November 2015 |
End Date: | October 31, 2019 |
STOP-JIA is a PCORI funded prospective observational study which will compare the clinical
effectiveness and impact on patient reported outcomes of 3 Childhood Arthritis & Rheumatology
Research Alliance (CARRA) consensus derived treatment strategies (CTPs) in new-onset
polyarticular JIA (pJIA) patients to answer the critical question of when is the best time to
begin biologic medications to achieve the optimal clinical and patient reported outcomes.
Because the CARRA Registry will be used for data collection, all patients will be enrolled in
the CARRA Registry. The standard of care treatments are chosen by the treating physician and
patient/caregiver and are not randomized.
effectiveness and impact on patient reported outcomes of 3 Childhood Arthritis & Rheumatology
Research Alliance (CARRA) consensus derived treatment strategies (CTPs) in new-onset
polyarticular JIA (pJIA) patients to answer the critical question of when is the best time to
begin biologic medications to achieve the optimal clinical and patient reported outcomes.
Because the CARRA Registry will be used for data collection, all patients will be enrolled in
the CARRA Registry. The standard of care treatments are chosen by the treating physician and
patient/caregiver and are not randomized.
STOP-JIA is a prospective, observational study comparing the clinical effectiveness and
impact on patient reported outcomes of 3 different treatment strategies (CTPs) in new onset
pJIA patients to answer the critical question of when to start biologic medications. All
participants will be enrolled in the CARRA Registry and started on one of the CTPs, which
will be decided by the treating physician and patient/caregiver. Subjects will be enrolled at
one of 60 participating CARRA sites across the US and Canada. Total anticipated enrollment is
>400, or 200 patients per year over 2 years of recruitment.
Specific Aim 1:
To compare the clinical effectiveness of different strategies (CTPs) for using biologic
medications in achieving clinically inactive disease (CID) at 12 months in new-onset pJIA.
Three common strategies that differ in the timing of biologic medication introduction will be
compared: 1) Step-Up: disease modifying anti-rheumatic drug (DMARD) monotherapy stepping up
by addition of a biologic medication if needed; 2) Early Combination: DMARD plus biologic
medication at treatment onset; and 3) Biologic First: biologic medication monotherapy at
treatment onset.
Hypothesis 1: A significantly higher proportion of children started on a biologic medication
at onset (CTP 2 or 3) will achieve CID after 12 months of therapy compared to standard
therapy (CTP 1).
Specific Aim 2:
To compare patient and caregiver reported outcomes between the different strategies.
Hypothesis 2: There will be statistically significant differences in patient/caregiver
reported outcomes (PROs) between treatment strategies that can inform future patients and
providers in selecting optimal treatments.
The CARRA Registry will be housed at CARRA's clinical and data coordinating center, Duke
Clinical Research Institute (DCRI). The CARRA Registry Protocol documents that the CARRA
Registry fulfills all PCOR standards for registries. STOP-JIA will utilize data collection,
storage, and management processes, systems requirements, and security processes already
established for the CARRA Registry at DCRI.
STOP-JIA will use Web-based electronic CRFs (eCRFs) developed for the CARRA Registry that are
already familiar to site personnel. The eCRF platform, RAVE, is 21CFR part11 compliant and
meets regulatory requirements. Database and Web servers are secured by a firewall and through
controlled physical access. eCRFs will be monitored for completeness, accuracy, and attention
to detail throughout the study by DCRI data and site management teams using processes
developed for the CARRA Registry and consistent with DCRI's internal SOPs. Use of electronic
data capture will allow for immediate prompts/queries if entered values are out of expected
ranges or there are incomplete data fields. The design of the data collection instrument will
allow centers to record a planned assessment of a patient was missed and to enter any known
reasons for the assessment being missed. DCRI will regularly provide reports detailing data
completion metrics to the sites. Stakeholder engagement is also an important aspect of this
study, and patients/caregivers as well as other stakeholders are serving as research partners
and advisors in this study.
impact on patient reported outcomes of 3 different treatment strategies (CTPs) in new onset
pJIA patients to answer the critical question of when to start biologic medications. All
participants will be enrolled in the CARRA Registry and started on one of the CTPs, which
will be decided by the treating physician and patient/caregiver. Subjects will be enrolled at
one of 60 participating CARRA sites across the US and Canada. Total anticipated enrollment is
>400, or 200 patients per year over 2 years of recruitment.
Specific Aim 1:
To compare the clinical effectiveness of different strategies (CTPs) for using biologic
medications in achieving clinically inactive disease (CID) at 12 months in new-onset pJIA.
Three common strategies that differ in the timing of biologic medication introduction will be
compared: 1) Step-Up: disease modifying anti-rheumatic drug (DMARD) monotherapy stepping up
by addition of a biologic medication if needed; 2) Early Combination: DMARD plus biologic
medication at treatment onset; and 3) Biologic First: biologic medication monotherapy at
treatment onset.
Hypothesis 1: A significantly higher proportion of children started on a biologic medication
at onset (CTP 2 or 3) will achieve CID after 12 months of therapy compared to standard
therapy (CTP 1).
Specific Aim 2:
To compare patient and caregiver reported outcomes between the different strategies.
Hypothesis 2: There will be statistically significant differences in patient/caregiver
reported outcomes (PROs) between treatment strategies that can inform future patients and
providers in selecting optimal treatments.
The CARRA Registry will be housed at CARRA's clinical and data coordinating center, Duke
Clinical Research Institute (DCRI). The CARRA Registry Protocol documents that the CARRA
Registry fulfills all PCOR standards for registries. STOP-JIA will utilize data collection,
storage, and management processes, systems requirements, and security processes already
established for the CARRA Registry at DCRI.
STOP-JIA will use Web-based electronic CRFs (eCRFs) developed for the CARRA Registry that are
already familiar to site personnel. The eCRF platform, RAVE, is 21CFR part11 compliant and
meets regulatory requirements. Database and Web servers are secured by a firewall and through
controlled physical access. eCRFs will be monitored for completeness, accuracy, and attention
to detail throughout the study by DCRI data and site management teams using processes
developed for the CARRA Registry and consistent with DCRI's internal SOPs. Use of electronic
data capture will allow for immediate prompts/queries if entered values are out of expected
ranges or there are incomplete data fields. The design of the data collection instrument will
allow centers to record a planned assessment of a patient was missed and to enter any known
reasons for the assessment being missed. DCRI will regularly provide reports detailing data
completion metrics to the sites. Stakeholder engagement is also an important aspect of this
study, and patients/caregivers as well as other stakeholders are serving as research partners
and advisors in this study.
Inclusion Criteria:
- Age less than 19 at baseline (if 18 or older, agrees to be followed for at least one
year)
- Diagnosis of Arthritis per ACR definition.
- Arthritis present in one joint for a least six weeks
- At least 5 active joints at baseline
- Contraception if sexually active (male and female)
May have any of the following:
- RF+ polyarticular JIA
- RF- polyarticular JIA
- Extended oligoarticular JIA
- Psoriatic JIA
- Enthesitis related JIA
- Undifferentiated JIA
- Psoriasis
- Sacroiliitis
- Uveitis
- Enthesitis
- Prior treatments permitted:
- NSAIDS
- Hydroxychloroquine
- Intraocular / topical / intraarticular glucocorticoids
- IV or PO steroids if one of the below criteria are met:
--If treated ≤ 3 months prior to baseline: treatment cannot exceed 2 weeks
--If treated > 3 months prior to baseline: any treatment course is permitted as
long as treatment was completed 90 days prior to baseline
- Methotrexate started no more than 1 month prior to the baseline visit
- Biologics — received only 1 dose within 1 week of the baseline visit
Exclusion Criteria:
- Features consistent with systemic JIA
- Treatment with any medications for JIA aside from those listed above.
- Known inflammatory bowel disease
- Known celiac disease
- Known Trisomy 21
- History of or current malignancy
- Concomitant serious active or recurrent chronic bacterial, fungal or viral infection
- Significant organ system disorder limiting use of treatments for pJIA
- Live vaccine within a month prior to baseline
We found this trial at
53
sites
Click here to add this to my saved trials
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
Click here to add this to my saved trials
Tufts Medical Center Tufts Medical Center is an internationally-respected academic medical center – a teaching...
Click here to add this to my saved trials
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
Cincinnati, Ohio 45229
1-513-636-4200
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
Click here to add this to my saved trials
Nationwide Children's Hospital At Nationwide Children’s, we are creating the future of pediatric health care....
Click here to add this to my saved trials
Univ of Texas, Southwestern Med Ctr of Dallas The story of UT Southwestern Medical Center...
Click here to add this to my saved trials
Connecticut Children's Medical Center Connecticut Children’s Medical Center is a nationally recognized, 187-bed not-for-profit children’s...
Click here to add this to my saved trials
Children's Mercy Hospital Children's Mercy Hospitals and Clinics continues redefining pediatric medicine throughout the Midwest...
Click here to add this to my saved trials
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
Click here to add this to my saved trials
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
Click here to add this to my saved trials
Click here to add this to my saved trials
4401 Penn Avenue
Pittsburgh, Pennsylvania 15224
Pittsburgh, Pennsylvania 15224
412-692-5325
Children's Hospital of Pittsburgh of UPMC UPMC is one of the leading nonprofit health systems...
Click here to add this to my saved trials
Rady Children's Hospital - San Diego Rady Children's Hospital-San Diego is the region’s pediatric medical...
Click here to add this to my saved trials
Albany Medical College Albany Medical Center is northeastern New York's only academic health sciences center...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Children's Hospital Colorado At Children's Hospital Colorado, we see more, treat more and heal more...
Click here to add this to my saved trials
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
University of Chicago Medical Center The University of Chicago Medicine has been at the forefront...
Click here to add this to my saved trials
225 E Chicago Ave
Chicago, Illinois 60611
Chicago, Illinois 60611
(312) 227-4000
Ann & Robert H. Lurie Children's Hospital of Chicago Ann & Robert H. Lurie Children
Click here to add this to my saved trials
Click here to add this to my saved trials
MetroHealth Med Ctr The MetroHealth System is one of the largest, most comprehensive health care...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
340 W 10th St #6200
Indianapolis, Indiana 46202
Indianapolis, Indiana 46202
(317) 274-3772
Indiana University School of Medicine With more than 2,000 students in 2013, the Indiana University...
Click here to add this to my saved trials
University of Iowa Hospitals and Clinics University of Iowa Hospitals and Clinics—recognized as one of...
Click here to add this to my saved trials
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Hospital for Special Surgery Founded in 1863, Hospital for Special Surgery is the nation
Click here to add this to my saved trials
New York University Langone Medical Center NYU NYU Langone Medical Center, a world-class, patient-centered, integrated,...
Click here to add this to my saved trials
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
505 Parnassus Ave
San Francisco, California 94143
San Francisco, California 94143
(415) 476-1000
University of California, San Francisco Medical Center UCSF Medical Center is recognized throughout the world...
Click here to add this to my saved trials
Seattle Children's Hospital Seattle Children’s Hospital specializes in meeting the unique physical, emotional and developmental...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials